Reasons to Add AngioDynamics Stock to Your Portfolio for Now [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
The optimism, led by a solid second-quarter fiscal 2026 performance, positive ongoing studies and a broad product line, bodes well for the stock. In the last six-month period, the Zacks Rank #1 (Strong Buy) company's shares have gained 9.8% compared with 5.2% growth of the industry. The S&P 500 has increased 11.9% during the said time frame. The renowned designer, manufacturer and seller of an extensive range of innovative medical, surgical and diagnostic devices has a market capitalization of $422.1 million. The company projects 51.9% growth over the next year and expects to witness continued improvements in its business. AngioDynamics' earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 82.1%. Image Source: Zacks Investment Research NanoKnife Driving Growth: During the second quarter of fiscal 2026, management highlighted continued strength in the NanoKnife franchise, with revenue increasing 22.2% year over year and p
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- ????????????????????????????2035????4?2330??????????? [CNET News]CNET News
- AngioDynamics (NASDAQ:ANGO) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic [Yahoo! Finance]Yahoo! Finance
- AngioDynamics J.P. Morgan Conference: MedTech Growth Push, Cash-Flow Path, CEO Retirement Plan [Yahoo! Finance]Yahoo! Finance
- AngioDynamics (NASDAQ:ANGO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
ANGO
Earnings
- 1/6/26 - Beat
ANGO
Sec Filings
- 1/14/26 - Form 8-K
- 1/8/26 - Form SCHEDULE
- 1/6/26 - Form 10-Q
- ANGO's page on the SEC website